Elize Massard da Fonseca in research grants and scholarships supported by FAPESP.
| Articles published in Pesquisa FAPESP Magazine about the researcher: |
| El tejido de las políticas sanitarias |
| Crafting healthcare policy |
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
This research will continue the study of the health industry complex (CIS), an array of instruments to align health policy with industrial policy. We began this research a decade ago, and we now aim to expand it to the case of COVID-19. The pandemic has shifted the incentives of biomedical innovation, promoted collaboration among drug regulatory agencies in ways never seen before, and res…
The novel coronavirus (COVID-19) pandemic, which has resulted in high mortality and morbidity rates, represents a challenge to health systems and services across the globe. How have governments responded to this pandemic? What is the gap in timing between the emergence of cases in a given country and that government's decision to enact control measures? Perhaps more importantly: how and w…
This proposal aims at strengthening a four-year collaboration between Shadlen and Fonseca on studies related to regulation of pharmaceutical industries. This grant will allow us to fine-tune a typology for comparing national approaches toward the regulation of generic drugs, and to map out a research strategy for applying this typology in the Latin American. Generic drug substitution may …
The Brazilian government has invested in its pharmaceutical sector as part of an innovative strategy for economic and technological development. In parallel, it increased access to high-cost medicines such as drugs to treat cancer or AIDS through the National Health System. Social science scholars have paid relatively little attention to these initiatives, focusing instead on the impact o…
This research seeks to analyze the Brazilian strategy for developing national capabilities in biological drugs and vaccines production. One of the main axes proposed in this research regards the use of public procurement mechanisms, technological orders and the establishment of public-private partnerships to strength the national productive, scientific and technological capabilities withi…
The 1988 Brazilian constitution established the current Unified Health System, whose main principle is, amongst others, universal access to treatment and medications. Since then, although there have been periods characterized by expansion in the access to medications, such as the successful case of the National AIDS programme which effectively granted universal access to antiretrovirals (…
The student will be trained to investigate the interactions between bureaucracies and the power relations in the executive government to clarify governance strategies in complex policy arrangements, such as technology transfer and drug regulation. The student will contribute to data collection, systematization, and analysis of quantitative and qualitative data regarding the bureaucracy pr…
The student will make a historic recovery of the changes in the financing model of the Brazilian Unified Health System since the promulgation of the Federal Constitution of 1988 until the year 2016. He will seek to establish the causal network and the causal mechanisms that explain the development of the Brazilian health financing policy, which will require a refined understanding of the …
Ever since its beginning, in December 2016, the project "Policies for competitiveness in the pharmaceutical sector: an analysis of the Brazilian experience", led by researcher Elize Massard da Fonseca, has carried out analyzes and important results on policies involving products and services in the Industrial Health Complex in Brazil. Recently the project has strengthened ties with intern…
(Only some records are available in English at this moment)
This internship abroad is geared towards understanding how the COVID-19 pandemic affected the treatment of people living with HIV/AIDS (PLWA) in Brazil and the United States (U.S.). What were the consequences of the COVID-19 pandemic on PLWA patients in terms of public health outcomes (epidemiological effects), and what strategies were adopted by both countries to mitigate these consequen…
The COVID-19 pandemic is a great challenge for global public health, and it is testing health systems, evidencing, however, that state capacity is not enough to explain the countries performance in fighting disease. It is also necessary to analyze the "political capacity" to respond to epidemics. We are moving towards a consensus that the role of central governments and intergovernmental …
One of the critical problems of contemporary global health is how to provide access to life-saving direct-acting antivirals (DAAs) to treat the hepatitis C virus (HCV). DAAs are recently launched drugs that have demonstrated cure rates exceeding 90%, which has revolutionized the fight against this epidemic. Given the promising results of such therapies, the World Health Organization launc…
(Only some records are available in English at this moment)
| 1 / 1 | Ongoing research grants |
| 3 / 3 | Completed research grants |
| 3 / 3 | Ongoing scholarships in Brazil |
| 21 / 20 | Completed scholarships in Brazil |
| 6 / 6 | Completed scholarships abroad |
| 34 / 33 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID